Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced its debut on TIME and Statista's World's Most Sustainable Companies 2026 ...

Lupin Limited has been featured in TIME and Statista's World's Most Sustainable Companies 2026 list, marking the company's ...

Lupin reported 77 per cent hike in its net profit to Rs 801 crore for the June quarter of FY25. This is due to robust sales ...

Lupin Pharmaceuticals has recalled two batches of its Tydemy birth control pills after reporting defects The company’s earnings beat reported higher profits and revenues Lupin’s share price rose 4% at ...

Lupin is no stranger to FDA rebukes. After facing accusations of “inadequate” manufacturing operations writ large last summer, the generics juggernaut is apparently yet to clean up its act. Lupin’s ...

MUMBAI, India and NAPLES, Fla., June 26, 2026 /CNW/ — Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that it has ...

The Nifty Pharma index was trading slightly lower at 22,529.20, down 0.23 per cent, reflecting mixed sentiment across ...

MUMBAI, India and NAPLES, Fla, May 5, 2026 /PRNewswire/ -- Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that it ...

On the evening of February 8, at least 800 people assembled in Mumbai for the launch of Made in India, a biography of Desh Bandhu Gupta (DBG), a chemistry professor who started Lupin Laboratories in ...

In the past month, the Nifty Pharma index outperformed the market by surging 7.4 per cent, as compared to 4.2 per cent rise ...

MUMBAI, India--(BUSINESS WIRE)--Pharma major Lupin Limited (Lupin) and global biopharmaceutical company AbbVie Inc., today announced that AbbVie has licensed Lupin’s MALT1 (Mucosa-Associated Lymphoid ...